EDAP TMS SA
NASDAQ: EDAP (EDAP TMS S.A.)
Last update: 15 hours ago3.47
0.15 (4.52%)
| Previous Close | 3.32 |
| Open | 3.35 |
| Volume | 18,853 |
| Avg. Volume (3M) | 47,977 |
| Market Cap | 130,062,488 |
| Price / Sales | 1.71 |
| Price / Book | 6.23 |
| 52 Weeks Range | |
| Earnings Date | 7 May 2026 |
| Profit Margin | -34.33% |
| Operating Margin (TTM) | -44.22% |
| Diluted EPS (TTM) | -0.680 |
| Quarterly Revenue Growth (YOY) | -9.10% |
| Total Debt/Equity (MRQ) | 36.23% |
| Current Ratio (MRQ) | 1.74 |
| Operating Cash Flow (TTM) | -14.91 M |
| Levered Free Cash Flow (TTM) | -10.11 M |
| Return on Assets (TTM) | -16.54% |
| Return on Equity (TTM) | -49.28% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Distribution (US) | Bullish | Mixed |
| Medical Distribution (Global) | Bullish | Mixed | |
| Stock | EDAP TMS S.A. | Mixed | Bearish |
AIStockmoo Score
| Analyst Consensus | 2.0 |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | -0.5 |
| Average | -0.13 |
|
Edap TMS SA is a holding company operating in three divisions namely, HIFU (High-Intensity Focused Ultrasound), ESWL (Extracorporeal ShockWave Lithotripsy), and Distribution. The HIFU division develops, manufactures, and markets devices for the invasive destruction of certain types of tumors using HIFU technology. It markets three HIFU devices: the Ablatherm, Ablatherm Fusion, and the Focal One. The ESWL division is engaged in the manufacturing, marketing, and servicing of its installed base of Sonolith range of lithotripters. The Distribution division markets products that are complementary to its globalized activity such as lasers, micro-ultrasound systems, and other medical products from third parties. Its geographical segments are Asia, France, United States, and Others. |
|
| Sector | Healthcare |
| Industry | Medical Distribution |
| Investment Style | Small Value |
| % Held by Institutions | 41.46% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Rock Springs Capital Management Lp | 31 Dec 2025 | 1,286,500 |
| Flax Pond Capital, Llc | 31 Dec 2025 | 797,246 |
| Bruce & Co., Inc. | 31 Dec 2025 | 438,652 |
| Parkman Healthcare Partners Llc | 31 Dec 2025 | 154,832 |
| Cahill Financial Advisors Inc | 31 Dec 2025 | 134,960 |
| Sage Mountain Advisors Llc | 31 Dec 2025 | 100,000 |
| Leonteq Securities Ag | 31 Mar 2026 | 94,990 |
| Commonwealth Equity Services, Llc | 31 Mar 2026 | 69,160 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |